Nestlé Says Weight-Loss Drugs Haven’t Hit Sales and Could Provide Opportunity

Is the rise of weight-loss drugs [hurting demand for snacks](https://ift.tt/FWm4ovt)? The packaged-foods giant, which also makes DiGiorno pizza, Maggi instant noodles and Nescafé coffee, said Thursday it hasn’t noticed any impact from the growing popularity of Ozempic and other similar drugs on its sales. For instance, Nestlé sees an opportunity to drive sales of Lean Cuisine, its frozen-meals brand, harder.